Improving the effectiveness of (-)-epigallocatechin gallate (EGCG) against rabbit atherosclerosis by EGCG-loaded nanoparticles prepared from chitosan and polyaspartic acid

Journal of Agricultural and Food Chemistry

Volumn 62, Issue 52, 2014, Pages 12603-12609

  Hong, Zhiyong ^a   Xu, Yongquan ^b   Yin, Jun Feng ^b   Jin, Jianchang ^a   Jiang, Yongwen ^b   Du, Qizhen ^a  

^a ZHEJIANG A F UNIVERSITY   (China)

^b BEIJING HOSPITAL   (China)

Author keywords

( ) Epigallocatechin gallate; Atherosclerosis; Effectiveness; Nanoparticles

Indexed keywords

AMINO ACIDS; CHITIN; CHITOSAN; DISEASES;

ATHEROSCLEROSIS; BIOACTIVE COMPOUNDS; EFFECTIVENESS; EPIGALLOCATECHIN GALLATE; GASTROINTESTINAL TRACT; HARSH ENVIRONMENT; POLYASPARTIC ACID; SELF ASSEMBLED NANOPARTICLES;

NANOPARTICLES;

ORYCTOLAGUS CUNICULUS;

CATECHIN; CHITOSAN; DRUG CARRIER; EPIGALLOCATECHIN GALLATE; NANOPARTICLE; PEPTIDE; POLYASPARTIC ACID;

ANALOGS AND DERIVATIVES; ANIMAL; ATHEROSCLEROSIS; BIOAVAILABILITY; CHEMISTRY; DRUG DELIVERY SYSTEM; EVALUATION STUDY; HUMAN; MALE; MEDICINAL CHEMISTRY; PARTICLE SIZE; PROCEDURES; RABBIT;

ANIMALS; ATHEROSCLEROSIS; BIOLOGICAL AVAILABILITY; CATECHIN; CHEMISTRY, PHARMACEUTICAL; CHITOSAN; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; HUMANS; MALE; NANOPARTICLES; PARTICLE SIZE; PEPTIDES; RABBITS;

EID: 84920180486     PISSN: 00218561     EISSN: 15205118     Source Type: Journal    
DOI: 10.1021/jf504603n     Document Type: Article

References (30)

1. Martinovic, I.; Abegunewardene, N.; Seul, M.; Vosseler, M.; Horstick, G.; Buerke, M.; Darius, H.; Lindemann, S. Elevated monocyte chemoattractant protein-1 serum levels in patients at risk for coronary artery disease. Circ. J. 2005, 69, 1484-1489.
2. Ross, R.; Harker, L. Hyperlipidemia and atherosclerosis. Science 1976, 193, 1094-1100.
3. Babu, P. V. A.; Si, H.; Liu, D. Epigallocatechin gallate reduces vascular inflammation in db/db mice possibly through an NF-κB-mediated mechanism. Mol. Nutr. Food Res. 2012, 56, 1424-432.
4. Yang, C. S.; Wang, X.; Lu, G.; Picinich, S. C. Cancer prevention by tea: animal studies, molecular mechanisms and human relevance. Nat. Rev. Cancer 2009, 9, 429-439.
5. Li, N.; Taylor, L. S.; Ferruzzi, M. G.; Mauer, L. J. Kinetic study of catechin stability: effects of pH, concentration, and temperature. J. Agric. Food Chem. 2012, 60, 12531-12539.
6. Wang, R.; Zhou, W. B.; Jiang, X. H. Reaction kinetics of degradation and epimerization of epigallocatechin gallate (EGCG) in aqueous system over a wide temperature range. J. Agric. Food Chem. 2008, 56, 2694-2701.
7. Li, N.; Taylor, L. S.; Ferruzzi, M. G.; Mauer, L. J. Color and chemical stability of tea polyphenol (-)-epigallocatechin-3-gallate in solution and solid states. Food Res. Int. 2013, 53, 909-921.
8. Wolfram, S. Effects of green tea and EGCG on cardiovascular and metabolic health. J. Am. Coll. Nutr. 2007, 26, 373s-388s.
9. Arab, L.; Liu, W.; Elashoff, D. Green and black tea consumption and risk of stroke: a meta-analysis. Stroke 2009, 40, 1786-1792.
10. Chen, L.; Lee, M. J.; Li, H.; Yang, C. S. Absorption, distribution, elimination of tea polyphenols in rats. Drug Metab. Dispos. 1997, 25, 1045-1050.
11. Warden, B. A.; Smith, L. S.; Beecher, G. R.; Balentine, D. A.; Clevidence, B. A. Catechins are bioavailable in men and women drinking black tea throughout the day. J. Nutr. 2001, 131, 1731-1737.
12. Lee, M. J.; Maliakal, P.; Chen, L.; Meng, X.; Bondoc, F. Y.; Prabhu, S.; Lambert, G.; Mohr, S.; Yang, C. S. Pharmacokinetics of tea catechins after ingestion of green tea and (-)-epigallocatechin-3-gallate by humans: formation of different metabolites and individual variability. Cancer Epidemiol. Biomarkers Prev. 2002, 11 (10 Part 1), 1025-1032.
13. Lambert, J. D.; Yang, C. S. Mechanisms of cancer prevention by tea constituents. J. Nutr. 2003, 133, 3262s-3267s.
14. Babu, R. V.; Liu, D. Green tea catechins and cardiovascular health: an update. Curr. Med. Chem. 2008, 15, 1840-1850.
15. Lambert, J. D.; Lee, M. J.; Diamond, L.; Ju, J.; Hong, J.; Bose, M.; Newmark, H. L.; Yang, C. S. Dose-dependent levels of epigallocatechin-3-gallate in human colon cancer cells and mouse plasma and tissues. Drug Metab. Dispos. 2006, 34, 8-11.
16. Su, Y. L.; Leung, L. K.; Huang, Y.; Chen, Z. Y. Stability of tea theaflavins and catechins. Food Chem. 2003, 83, 189-195.
17. Sang, S.; Lee, M. J.; Hou, Z.; Ho, C. T.; Yang, C. S. Stability of tea polyphenol (-)-epigallocatechin-3-gallate and formation of dimers and epimers under common experimental conditions. J. Agric. Food Chem. 2005, 53, 9478-9484.
18. Krook, M. A.; Hagerman, A. E. Stability of polyphenols epigallocatechin gallate and pentagalloyl glucose in a simulated digestive system. Food Res. Int. 2012, 49, 112-116.
19. Dube, A.; Ng, K.; Nicolazzo, J. A.; Larson, I. Effective use of reducing agents and nanoparticle encapsulation in stabilizing catechins in alkaline solution. Food Chem. 2010, 122, 662-667.
20. Dube, A.; Nicolazzo, J. A.; Larson, I. Chitosan nanoparticles enhance the plasma exposure of (-)-epigallocatechin gallate in mice through an enhancement in intestinal stability. Eur. J. Pharm. Sci. 2011, 44, 422-426.
21. Siddiqui, I. A.; Bharali, D. J.; Nihal, M.; Adhami, V. M.; Khan, N.; Chamcheu, J. C.; Khan, M. I.; Shabana, S.; Mousa, S. A.; Mukhtar, H. Excellent anti-proliferative and pro-apoptotic effects of (-)-epigallocatechin-3-gallate encapsulated in chitosan nanoparticles on human melanoma cell growth both in vivo. Nanomed. Nanotechnol. Biol. Med. 2014, 10, 1619-1626.
22. Zhang, J.; Nie, S.; Wang, S. Nanoencapsulation enhances epigallocatechin-3-gallate stability and its antiatherogenic bioactivities in macrophages. J. Agric. Food Chem. 2013, 61, 9200-9209.
23. Liu, W.; Ye, A.; Liu, C.; Liu, W.; Singh, H. Structure and integrity of liposomes prepared from milk- or soybean-derived phospholipids during in vitro digestion. Food Res. Int. 2012, 48, 499-506.
24. Tang, D.-W.; Yu, S.-H.; Ho, Y.-C.; Huang, B.-Q.; Tsai, G.-J.; Hsieh, H.-Y.; Sung, H.-W.; Mi, F.-L. Characterization of tea catechins-loaded nanoparticles prepared from chitosan and an edible polypeptide. Food Hydrocolloids 2013, 30, 33-41.
25. Stevanovic, M. M.; Skapin, S. D.; Bracko, I.; Milenkovic, M.; Petkovic, J.; Filipic, M.; Uskokovic, D. P. Poly(lactide-co-glycolide)/silver nanoparticles: synthesis, characterization, antimicrobial activity, cytotoxicity assessment and ROS-inducing potential. Polymer 2012, 53, 2818-2828.
26. Chithrani, B. D.; Ghazani, A. A.; Chan, W. C. W. Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett. 2006, 6, 662-668.
27. Kalantzi, L.; Goumas, K.; Kalioras, V.; Abrahamsson, B.; Dressman, J.; Reppas, C. Characterization of the human upper gastrointestinal contents under conditions stimulating bioavailability/bioequivalence studies. Pharm. Res. 2006, 23, 165-176.
28. Eaimtrakarn, S.; Itoh, Y.; Kishimoto, J. I.; Yoshikawa, Y.; Shibata, N.; Takada, K. Retention and transit of intestinal mucoadhesive films in rat small intestine. Int. J. Pharm. 2011, 224, 61-67.
29. Spencer, J. P. E. Metabolism of tea flavonoids in the gastrointestinal tract. J. Nutr. 2003, 133, 3255s-3261s.
30. Rodrigues, C. F.; Ascenc¸ão, K.; Silva, F. A.; Sarmento, B.; Oliveira, M. B.; Andrade, J. C. Drug-delivery systems of green tea catechins for improved stability and bioavailability. Curr. Med. Chem. 2013, 20, 4744-4757.